Alzheimer's disease is a growing problem, with more people getting it and dying from it every year. This is a serious issue that needs attention. One way to tackle this is by spotting it early. Genetic tests can help, but they aren't always easy to get. So, what else can we do? The answer might be
Dementia is a big deal. It's when your brain starts to slow down, and it's not just one thing. Alzheimer's disease (AD) and frontotemporal dementia (FTD) are two big types, and they act differently over time. The challenge is, they start off looking the same. So, spotting them early is super importa
Plantain, also known as Plantago lanceolata, is a common plant that has been used for centuries in traditional medicine. It's been recognized as safe by various pharmacopeias, which are like rulebooks for medicines. This study looked at how different parts of the plant, specifically the leaves, migh
Two big trials are underway to test a new drug called oral semaglutide. These trials, known as Evoke and Evoke+, are in their third phase and are looking at how safe and effective this drug is for people in the early stages of Alzheimer's disease. Why is this important? Well, Alzheimer's is a t
Alzheimer's disease is a tough opponent, but scientists are finding new ways to fight it. Gold nanoparticles, tiny particles made of gold, are proving to be a powerful tool in the battle against this neurodegenerative disease. These nanoparticles can be loaded with afzelin, a natural compound found
Alzheimer's disease and related dementias (ADRD) are a huge problem for many people, especially those from minority backgrounds. That's why a special program is helping young students from underrepresented groups learn about this issue. The program is called Inspiring Undergraduate Student Training
Imagine if there were drugs that could tackle brain diseases in a whole new way. Brain diseases like Parkinson's and Alzheimer's are tough. They cause brain cells to die. Most drugs out there just treat the symptoms. They don't fix the root cause. This is where hybrid drugs come in. These are specia
People often struggle to recognize Alzheimer's disease and related dementias. But, there are tiny hints in the blood that could help doctors. These are called blood-based biomarkers, or BBMs. They act as signals that something might be wrong in the brain. But what happens when someone has other heal
At first glance, tau and CPEB3 might seem like an unlikely duo. Tau is a protein that can go rogue and form harmful clumps in Alzheimer's disease. On the other hand, CPEB3 is essential for long-term memory and forms functional clumps to do its job. So, what happens when these two memory-related prot
Alzheimer's disease is a tough opponent in the world of neurodegenerative disorders. Early detection is crucial. Scientists have been trying to figure out the best ways to identify this disease early. They've decided to focus on two key biomarkers Aβ42 and Aβ40. These biomarkers are tiny clues th
